Back to Swedbank AB Swedbank AB

RPRXRPRX
Showing 8 of 21 quarters

Position history for Swedbank ABSwedbank AB's holdings in ROYALTY PHARMA PLC- CL A

Swedbank AB holds 10.7M shares of RPRX (ROYALTY PHARMA PLC- CL A), worth $601.4M as of 2026-Q2. The position was decreased (-7.4% shares). RPRX represents 0.5% of Swedbank AB's portfolio.

Current Value

$601.4M

Current Shares

10.7M

Total Value Change

+$289.5M

Total Shares Change

-300,762

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
10.7M
-7.4%
$601.4M0.5%$55.85
0
2026-Q1
Decreased
11.6M
-3.0%
$555.8M0.6%$47.57
0
2025-Q4
Decreased
11.9M
-2.1%
$461.4M0.4%$38.12
0
2025-Q3
Increased
12.2M
+0.3%
$430.4M0.4%$34.61
37
2025-Q2
Unchanged
12.2M
0.0%
$438M0.5%$35.13
0
2025-Q1
Decreased
12.2M
-0.1%
$378.5M0.5%$30.15
0
2024-Q4
Increased
12.2M
+10.3%
$310.3M0.4%$24.55
41
2024-Q3
Increased
11M
+2.0%
$312M0.4%$27.00
38

Other major holders of RPRX: MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used